Ghost Tree Capital, LLC 13F Holdings · last filed Q3 2024
Ghost Tree Capital, LLC reported 51 securities worth $331.04M in its SEC 13F filing for Q3 2024 (period ended 2024-09-30). Top holdings: XBI (8.95%), BHVN (5.26%), SRPT (4.53%). Among its top 25 positions this quarter: 3 new, 8 added, 14 trimmed.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | XBI | SPDR SER TR | $29.6M | 8.95% | 300,000 | New |
| 2 | BHVN | BIOHAVEN LTD | $17.4M | 5.26% | 348,778 | New |
| 3 | SRPT | SAREPTA THERAPEUTICS INC | $15.0M | 4.53% | 120,000 | Added |
| 4 | NVO | NOVO-NORDISK A S | $13.1M | 3.96% | 110,000 | New |
| 5 | BPMC | BLUEPRINT MEDICINES CORP | $12.9M | 3.91% | 140,000 | Added |
| 6 | AXSM | AXSOME THERAPEUTICS INC | $12.1M | 3.66% | 135,000 | Trimmed |
| 7 | TARS | TARSUS PHARMACEUTICALS INC | $11.5M | 3.48% | 350,000 | Added |
| 8 | CATX | PERSPECTIVE THERAPEUTICS INC | $10.0M | 3.02% | 750,000 | Trimmed |
| 9 | CGON | CG ONCOLOGY INC | $9.4M | 2.85% | 250,000 | Trimmed |
| 10 | ROIV | ROIVANT SCIENCES LTD | $9.2M | 2.79% | 800,000 | Trimmed |
| 11 | INSM | INSMED INC | $9.1M | 2.76% | 125,000 | Trimmed |
| 12 | PCVX | VAXCYTE INC | $9.1M | 2.76% | 80,000 | Trimmed |
| 13 | VKTX | VIKING THERAPEUTICS INC | $8.9M | 2.68% | 140,000 | Added |
| 14 | SNDX | SYNDAX PHARMACEUTICALS INC | $8.7M | 2.62% | 450,000 | Added |
| 15 | JANX | JANUX THERAPEUTICS INC | $8.6M | 2.61% | 190,000 | Added |
| 16 | ASND | ASCENDIS PHARMA A/S | $7.8M | 2.37% | 52,500 | Trimmed |
| 17 | CRBP | CORBUS PHARMACEUTICALS HLDGS | $7.8M | 2.37% | 380,000 | Added |
| 18 | CRNX | CRINETICS PHARMACEUTICALS IN | $7.7M | 2.32% | 150,000 | Trimmed |
| 19 | SLNO | SOLENO THERAPEUTICS INC | $7.6M | 2.29% | 150,000 | Trimmed |
| 20 | TGTX | TG THERAPEUTICS INC | $7.3M | 2.19% | 310,000 | Trimmed |
| 21 | RZLT | REZOLUTE INC | $7.2M | 2.16% | 1.5M | Added |
| 22 | PHAT | PHATHOM PHARMACEUTICALS INC | $6.8M | 2.05% | 375,000 | Trimmed |
| 23 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $6.5M | 1.96% | 128,411 | Trimmed |
| 24 | OLMA | OLEMA PHARMACEUTICALS INC | $6.4M | 1.93% | 535,000 | Trimmed |
| 25 | IMVT | IMMUNOVANT INC | $6.1M | 1.85% | 215,000 | Trimmed |
Source: SEC Form 13F filings · as of 2024-09-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR